KEFLEX DIN 00403628
Status: Dormant
Holder: PENDOPHARM DIVISION OF PHARMASCIENCE INC
Molecule: CEPHALEXIN (CEPHALEXIN MONOHYDRATE)
Health Canada record
| Active ingredient(s) | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 250 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01DB01 CEFALEXIN |
| Original market date | 31-Dec-1977 |
| Current status date | 03-Aug-2017 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CEPHALEXIN (CEPHALEXIN MONOHYDRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00768723 | APO-CEPHALEX | APOTEX INC | Tablet | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 250 MG | Marketed |
| 00768715 | APO-CEPHALEX | APOTEX INC | Tablet | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 500 MG | Marketed |
| 02496445 | ASN-CEPHALEXIN | ASCEND LABORATORIES LTD | Powder For Suspension | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 125 MG | Approved |
| 02496453 | ASN-CEPHALEXIN | ASCEND LABORATORIES LTD | Powder For Suspension | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 250 MG | Approved |
| 02497751 | AURO-CEPHALEXIN | AURO PHARMA INC | Powder For Suspension | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 250 MG | Marketed |
| 02470586 | AURO-CEPHALEXIN | AURO PHARMA INC | Tablet | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 500 MG | Marketed |
| 02470578 | AURO-CEPHALEXIN | AURO PHARMA INC | Tablet | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 250 MG | Marketed |
| 02497743 | AURO-CEPHALEXIN | AURO PHARMA INC | Powder For Suspension | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 125 MG | Marketed |
| 02463369 | CEFASEPTIN 300 MG | VETOQUINOL N A INC | Tablet (Chewable) | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 300 MG | Marketed |
| 02463350 | CEFASEPTIN 75 MG | VETOQUINOL N A INC | Tablet (Chewable) | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 75 MG | Approved |
| 02463385 | CEFASEPTIN 750 MG | VETOQUINOL N A INC | Tablet (Chewable) | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 750 MG | Marketed |
| 02495651 | CEPHALEXIN | SIVEM PHARMACEUTICALS ULC | Tablet | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 500 MG | Marketed |
| 02521261 | CEPHALEXIN | SANIS HEALTH INC | Tablet | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 500 MG | Marketed |
| 02521253 | CEPHALEXIN | SANIS HEALTH INC | Tablet | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 250 MG | Marketed |
| 02494698 | JAMP CEPHALEXIN | JAMP PHARMA CORPORATION | Tablet | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 250 MG | Marketed |
| 02494701 | JAMP CEPHALEXIN | JAMP PHARMA CORPORATION | Tablet | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 500 MG | Marketed |
| 02528436 | JAMP CEPHALEXIN SUSPENSION | JAMP PHARMA CORPORATION | Powder For Suspension | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 125 MG | Marketed |
| 02528444 | JAMP CEPHALEXIN SUSPENSION | JAMP PHARMA CORPORATION | Powder For Suspension | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 250 MG | Marketed |
| 02469189 | LUPIN-CEPHALEXIN | LUPIN PHARMA CANADA LIMITED | Powder For Suspension | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 250 MG | Marketed |
| 02471140 | LUPIN-CEPHALEXIN | LUPIN PHARMA CANADA LIMITED | Tablet | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 250 MG | Marketed |
| 02469170 | LUPIN-CEPHALEXIN | LUPIN PHARMA CANADA LIMITED | Powder For Suspension | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 125 MG | Marketed |
| 02471159 | LUPIN-CEPHALEXIN | LUPIN PHARMA CANADA LIMITED | Tablet | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 500 MG | Marketed |
| 02562596 | PRO-CEPHALEXIN | PRO DOC LIMITEE | Powder For Suspension | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 250 MG | Marketed |
| 02562588 | PRO-CEPHALEXIN | PRO DOC LIMITEE | Powder For Suspension | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 125 MG | Approved |
| 02442701 | RILEXINE CHEWABLE TABLETS | VIRBAC AH, INC. | Tablet (Chewable) | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 300 MG | Marketed |
| 02442698 | RILEXINE CHEWABLE TABLETS | VIRBAC AH, INC. | Tablet (Chewable) | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 150 MG | Approved |
| 02442728 | RILEXINE CHEWABLE TABLETS | VIRBAC AH, INC. | Tablet (Chewable) | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 600 MG | Marketed |
| 00342084 | TEVA-CEPHALEXIN | TEVA CANADA LIMITED | Capsule | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 250 MG | Marketed |
| 00583421 | TEVA-CEPHALEXIN | TEVA CANADA LIMITED | Tablet | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 500 MG | Marketed |
| 00583413 | TEVA-CEPHALEXIN | TEVA CANADA LIMITED | Tablet | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 250 MG | Marketed |
| 00342114 | TEVA-CEPHALEXIN | TEVA CANADA LIMITED | Capsule | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 500 MG | Marketed |
| 00342106 | TEVA-CEPHALEXIN 125 | TEVA CANADA LIMITED | Powder For Suspension | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 125 MG | Marketed |
| 00342092 | TEVA-CEPHALEXIN 250 | TEVA CANADA LIMITED | Powder For Suspension | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 250 MG | Marketed |
| 00828866 | CEPHALEXIN-500 | PRO DOC LIMITEE | Tablet | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 500 MG | Cancelled Post Market |
| 00244392 | KEFLEX | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Tablet | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 500 MG | Dormant |
| 02229587 | PENTA-CEPHALEXIN - 250MG | PENTAPHARM LTD. | Tablet | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 250 MG | Cancelled Post Market |
| 02229588 | PENTA-CEPHALEXIN - 500MG | PENTAPHARM LTD. | Tablet | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 500 MG | Cancelled Post Market |
| 02353911 | VETOLEXIN 100 | VETOQUINOL N A INC | Paste | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 100 MG | Cancelled Post Market |
| 02353938 | VETOLEXIN 250 | VETOQUINOL N A INC | Paste | CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 250 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 13351 | 2012-06-05 | New Drug Submission (NDS) | Manufacturer name change |
| 10640 | 2009-10-05 | New Drug Submission (NDS) | Manufacturer name change |
| 349 | 2002-07-30 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 388 | 2002-02-04 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |